Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,179
archived clinical trials in
Anxiety

Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors
Worry, Uncertainty and Insomnia: A Cognitive-behavioral Intervention for Cancer Survivors
Status: Enrolling
Updated:  4/4/2017
Wexner Medical Center at The Ohio State University Department of Psychiatry
mi
from
Columbus, OH
Cognitive-Behavioral Intervention for Worry, Uncertainty, and Insomnia for Cancer Survivors
Worry, Uncertainty and Insomnia: A Cognitive-behavioral Intervention for Cancer Survivors
Status: Enrolling
Updated: 4/4/2017
Wexner Medical Center at The Ohio State University Department of Psychiatry
mi
from
Columbus, OH
Click here to add this to my saved trials
The Implantable Cardioverter-defibrillators (ICD)/Device Expectations, Adaptations, and Successes Study
The ICD/Device Expectations, Adaptations, and Successes (IDEAS) Study: the Relationship Between Implantable Cardioverter-defibrillators, Pacemakers and Psychiatric Symptoms in a Pediatric Population
Status: Enrolling
Updated:  4/12/2017
Children's Hospital Boston
mi
from
Boston, MA
The Implantable Cardioverter-defibrillators (ICD)/Device Expectations, Adaptations, and Successes Study
The ICD/Device Expectations, Adaptations, and Successes (IDEAS) Study: the Relationship Between Implantable Cardioverter-defibrillators, Pacemakers and Psychiatric Symptoms in a Pediatric Population
Status: Enrolling
Updated: 4/12/2017
Children's Hospital Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Adjunctive Quetiapine in the Treatment of Refractory Social Anxiety Disorder in Adults
A Double-Blind, Placebo-Controlled, Flexible-Dosage Study to Evaluate the Efficacy and Safety of Adjunctive Quetiapine in the Treatment of Refractory Social Anxiety Disorder in Adults
Status: Enrolling
Updated:  4/17/2017
Cambridge Health Alliance
mi
from
Cambridge, MA
Adjunctive Quetiapine in the Treatment of Refractory Social Anxiety Disorder in Adults
A Double-Blind, Placebo-Controlled, Flexible-Dosage Study to Evaluate the Efficacy and Safety of Adjunctive Quetiapine in the Treatment of Refractory Social Anxiety Disorder in Adults
Status: Enrolling
Updated: 4/17/2017
Cambridge Health Alliance
mi
from
Cambridge, MA
Click here to add this to my saved trials
Cranial Electro Therapy Stimulation in Reducing Perioperative Anxiety
The Effect of Cranial Electro Therapy Stimulation in Reducing Perioperative Anxiety for Patients Undergoing First Eye Cataract Surgery
Status: Enrolling
Updated:  4/19/2017
Oklahoma City VA Medical Center
mi
from
Oklahoma City, OK
Cranial Electro Therapy Stimulation in Reducing Perioperative Anxiety
The Effect of Cranial Electro Therapy Stimulation in Reducing Perioperative Anxiety for Patients Undergoing First Eye Cataract Surgery
Status: Enrolling
Updated: 4/19/2017
Oklahoma City VA Medical Center
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Baclofen for Treating Anxiety and Alcoholism
A Double-Blind, Placebo-Controlled, Randomized Human Laboratory Pilot Study of Baclofen in Anxious Alcoholics
Status: Enrolling
Updated:  4/20/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Baclofen for Treating Anxiety and Alcoholism
A Double-Blind, Placebo-Controlled, Randomized Human Laboratory Pilot Study of Baclofen in Anxious Alcoholics
Status: Enrolling
Updated: 4/20/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Ginger.io Behavioral Health Study
Ginger.io Behavioral Health Study
Status: Enrolling
Updated:  4/24/2017
Community Health Center, Inc.-Meriden
mi
from
Meriden, CT
Ginger.io Behavioral Health Study
Ginger.io Behavioral Health Study
Status: Enrolling
Updated: 4/24/2017
Community Health Center, Inc.-Meriden
mi
from
Meriden, CT
Click here to add this to my saved trials
Ginger.io Behavioral Health Study
Ginger.io Behavioral Health Study
Status: Enrolling
Updated:  4/24/2017
Community Health Center, Inc.- Middletown
mi
from
Middletown, CT
Ginger.io Behavioral Health Study
Ginger.io Behavioral Health Study
Status: Enrolling
Updated: 4/24/2017
Community Health Center, Inc.- Middletown
mi
from
Middletown, CT
Click here to add this to my saved trials
Ginger.io Behavioral Health Study
Ginger.io Behavioral Health Study
Status: Enrolling
Updated:  4/24/2017
Community Health Center, Inc.-New Britain
mi
from
New Britain, CT
Ginger.io Behavioral Health Study
Ginger.io Behavioral Health Study
Status: Enrolling
Updated: 4/24/2017
Community Health Center, Inc.-New Britain
mi
from
New Britain, CT
Click here to add this to my saved trials
Ginger.io Behavioral Health Study
Ginger.io Behavioral Health Study
Status: Enrolling
Updated:  4/24/2017
Community Health Center, Inc.-New London
mi
from
New London, CT
Ginger.io Behavioral Health Study
Ginger.io Behavioral Health Study
Status: Enrolling
Updated: 4/24/2017
Community Health Center, Inc.-New London
mi
from
New London, CT
Click here to add this to my saved trials
Presence of a Companion During Performance of Neuraxial Labor Analgesia
Presence of a Companion During Performance of Neuraxial Labor Analgesia
Status: Enrolling
Updated:  5/18/2017
Prentice Women's Hospital
mi
from
Chicago, IL
Presence of a Companion During Performance of Neuraxial Labor Analgesia
Presence of a Companion During Performance of Neuraxial Labor Analgesia
Status: Enrolling
Updated: 5/18/2017
Prentice Women's Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Opioid Treatment for Chronic Low Back Pain and the Impact of Mood Symptoms
Opioid Treatment for Chronic Low Back Pain and the Impact of Mood Symptoms
Status: Enrolling
Updated:  6/7/2017
Brigham and Women's Hospital
mi
from
Chestnut Hill, MA
Opioid Treatment for Chronic Low Back Pain and the Impact of Mood Symptoms
Opioid Treatment for Chronic Low Back Pain and the Impact of Mood Symptoms
Status: Enrolling
Updated: 6/7/2017
Brigham and Women's Hospital
mi
from
Chestnut Hill, MA
Click here to add this to my saved trials
Smoking Cessation for Depression and Anxiety Treatment
Integrated Smoking Cessation Treatment for Emotional Dysregulation
Status: Enrolling
Updated:  7/6/2017
Anxiety and Health Research Laboratory and Substance Use Treatment Clinic
mi
from
Houston, TX
Smoking Cessation for Depression and Anxiety Treatment
Integrated Smoking Cessation Treatment for Emotional Dysregulation
Status: Enrolling
Updated: 7/6/2017
Anxiety and Health Research Laboratory and Substance Use Treatment Clinic
mi
from
Houston, TX
Click here to add this to my saved trials
Treatment Of Patients With Social Anxiety Disorder
Study CRH103390: A 12 Week Flexible Dose Study of GW876008, Placebo and Active Control (Paroxetine) in the Treatment of Social Anxiety Disorder (SocAD)
Status: Enrolling
Updated:  7/10/2017
GSK Investigational Site
mi
from
Beverly Hills, CA
Treatment Of Patients With Social Anxiety Disorder
Study CRH103390: A 12 Week Flexible Dose Study of GW876008, Placebo and Active Control (Paroxetine) in the Treatment of Social Anxiety Disorder (SocAD)
Status: Enrolling
Updated: 7/10/2017
GSK Investigational Site
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Treatment Of Patients With Social Anxiety Disorder
Study CRH103390: A 12 Week Flexible Dose Study of GW876008, Placebo and Active Control (Paroxetine) in the Treatment of Social Anxiety Disorder (SocAD)
Status: Enrolling
Updated:  7/10/2017
GSK Investigational Site
mi
from
Burbank, CA
Treatment Of Patients With Social Anxiety Disorder
Study CRH103390: A 12 Week Flexible Dose Study of GW876008, Placebo and Active Control (Paroxetine) in the Treatment of Social Anxiety Disorder (SocAD)
Status: Enrolling
Updated: 7/10/2017
GSK Investigational Site
mi
from
Burbank, CA
Click here to add this to my saved trials
Treatment Of Patients With Social Anxiety Disorder
Study CRH103390: A 12 Week Flexible Dose Study of GW876008, Placebo and Active Control (Paroxetine) in the Treatment of Social Anxiety Disorder (SocAD)
Status: Enrolling
Updated:  7/10/2017
GSK Investigational Site
mi
from
Temecula, CA
Treatment Of Patients With Social Anxiety Disorder
Study CRH103390: A 12 Week Flexible Dose Study of GW876008, Placebo and Active Control (Paroxetine) in the Treatment of Social Anxiety Disorder (SocAD)
Status: Enrolling
Updated: 7/10/2017
GSK Investigational Site
mi
from
Temecula, CA
Click here to add this to my saved trials
Treatment Of Patients With Social Anxiety Disorder
Study CRH103390: A 12 Week Flexible Dose Study of GW876008, Placebo and Active Control (Paroxetine) in the Treatment of Social Anxiety Disorder (SocAD)
Status: Enrolling
Updated:  7/10/2017
GSK Investigational Site
mi
from
Miami, FL
Treatment Of Patients With Social Anxiety Disorder
Study CRH103390: A 12 Week Flexible Dose Study of GW876008, Placebo and Active Control (Paroxetine) in the Treatment of Social Anxiety Disorder (SocAD)
Status: Enrolling
Updated: 7/10/2017
GSK Investigational Site
mi
from
Miami, FL
Click here to add this to my saved trials
Treatment Of Patients With Social Anxiety Disorder
Study CRH103390: A 12 Week Flexible Dose Study of GW876008, Placebo and Active Control (Paroxetine) in the Treatment of Social Anxiety Disorder (SocAD)
Status: Enrolling
Updated:  7/10/2017
GSK Investigational Site
mi
from
Orlando, FL
Treatment Of Patients With Social Anxiety Disorder
Study CRH103390: A 12 Week Flexible Dose Study of GW876008, Placebo and Active Control (Paroxetine) in the Treatment of Social Anxiety Disorder (SocAD)
Status: Enrolling
Updated: 7/10/2017
GSK Investigational Site
mi
from
Orlando, FL
Click here to add this to my saved trials
Treatment Of Patients With Social Anxiety Disorder
Study CRH103390: A 12 Week Flexible Dose Study of GW876008, Placebo and Active Control (Paroxetine) in the Treatment of Social Anxiety Disorder (SocAD)
Status: Enrolling
Updated:  7/10/2017
GSK Investigational Site
mi
from
Smyrna, GA
Treatment Of Patients With Social Anxiety Disorder
Study CRH103390: A 12 Week Flexible Dose Study of GW876008, Placebo and Active Control (Paroxetine) in the Treatment of Social Anxiety Disorder (SocAD)
Status: Enrolling
Updated: 7/10/2017
GSK Investigational Site
mi
from
Smyrna, GA
Click here to add this to my saved trials
Treatment Of Patients With Social Anxiety Disorder
Study CRH103390: A 12 Week Flexible Dose Study of GW876008, Placebo and Active Control (Paroxetine) in the Treatment of Social Anxiety Disorder (SocAD)
Status: Enrolling
Updated:  7/10/2017
GSK Investigational Site
mi
from
Oakbrook Terrace, IL
Treatment Of Patients With Social Anxiety Disorder
Study CRH103390: A 12 Week Flexible Dose Study of GW876008, Placebo and Active Control (Paroxetine) in the Treatment of Social Anxiety Disorder (SocAD)
Status: Enrolling
Updated: 7/10/2017
GSK Investigational Site
mi
from
Oakbrook Terrace, IL
Click here to add this to my saved trials
Treatment Of Patients With Social Anxiety Disorder
Study CRH103390: A 12 Week Flexible Dose Study of GW876008, Placebo and Active Control (Paroxetine) in the Treatment of Social Anxiety Disorder (SocAD)
Status: Enrolling
Updated:  7/10/2017
GSK Investigational Site
mi
from
Rockville, MD
Treatment Of Patients With Social Anxiety Disorder
Study CRH103390: A 12 Week Flexible Dose Study of GW876008, Placebo and Active Control (Paroxetine) in the Treatment of Social Anxiety Disorder (SocAD)
Status: Enrolling
Updated: 7/10/2017
GSK Investigational Site
mi
from
Rockville, MD
Click here to add this to my saved trials
Treatment Of Patients With Social Anxiety Disorder
Study CRH103390: A 12 Week Flexible Dose Study of GW876008, Placebo and Active Control (Paroxetine) in the Treatment of Social Anxiety Disorder (SocAD)
Status: Enrolling
Updated:  7/10/2017
GSK Investigational Site
mi
from
Farmington Hills, MI
Treatment Of Patients With Social Anxiety Disorder
Study CRH103390: A 12 Week Flexible Dose Study of GW876008, Placebo and Active Control (Paroxetine) in the Treatment of Social Anxiety Disorder (SocAD)
Status: Enrolling
Updated: 7/10/2017
GSK Investigational Site
mi
from
Farmington Hills, MI
Click here to add this to my saved trials
Treatment Of Patients With Social Anxiety Disorder
Study CRH103390: A 12 Week Flexible Dose Study of GW876008, Placebo and Active Control (Paroxetine) in the Treatment of Social Anxiety Disorder (SocAD)
Status: Enrolling
Updated:  7/10/2017
GSK Investigational Site
mi
from
Nutley, NJ
Treatment Of Patients With Social Anxiety Disorder
Study CRH103390: A 12 Week Flexible Dose Study of GW876008, Placebo and Active Control (Paroxetine) in the Treatment of Social Anxiety Disorder (SocAD)
Status: Enrolling
Updated: 7/10/2017
GSK Investigational Site
mi
from
Nutley, NJ
Click here to add this to my saved trials
Treatment Of Patients With Social Anxiety Disorder
Study CRH103390: A 12 Week Flexible Dose Study of GW876008, Placebo and Active Control (Paroxetine) in the Treatment of Social Anxiety Disorder (SocAD)
Status: Enrolling
Updated:  7/10/2017
GSK Investigational Site
mi
from
New York, NY
Treatment Of Patients With Social Anxiety Disorder
Study CRH103390: A 12 Week Flexible Dose Study of GW876008, Placebo and Active Control (Paroxetine) in the Treatment of Social Anxiety Disorder (SocAD)
Status: Enrolling
Updated: 7/10/2017
GSK Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
Treatment Of Patients With Social Anxiety Disorder
Study CRH103390: A 12 Week Flexible Dose Study of GW876008, Placebo and Active Control (Paroxetine) in the Treatment of Social Anxiety Disorder (SocAD)
Status: Enrolling
Updated:  7/10/2017
GSK Investigational Site
mi
from
Media, PA
Treatment Of Patients With Social Anxiety Disorder
Study CRH103390: A 12 Week Flexible Dose Study of GW876008, Placebo and Active Control (Paroxetine) in the Treatment of Social Anxiety Disorder (SocAD)
Status: Enrolling
Updated: 7/10/2017
GSK Investigational Site
mi
from
Media, PA
Click here to add this to my saved trials
Treatment Of Patients With Social Anxiety Disorder
Study CRH103390: A 12 Week Flexible Dose Study of GW876008, Placebo and Active Control (Paroxetine) in the Treatment of Social Anxiety Disorder (SocAD)
Status: Enrolling
Updated:  7/10/2017
GSK Investigational Site
mi
from
Edmonton,
Treatment Of Patients With Social Anxiety Disorder
Study CRH103390: A 12 Week Flexible Dose Study of GW876008, Placebo and Active Control (Paroxetine) in the Treatment of Social Anxiety Disorder (SocAD)
Status: Enrolling
Updated: 7/10/2017
GSK Investigational Site
mi
from
Edmonton,
Click here to add this to my saved trials
Using the PHQ-9 and GAD-7 as Feedback Instruments in Brief Psychotherapy
Using the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder 7-Item Scale (GAD-7) as Feedback Instruments in Brief Psychotherapy
Status: Enrolling
Updated:  7/18/2017
Christiana Care Health System - Adult Bridge Program
mi
from
Wilmington, DE
Using the PHQ-9 and GAD-7 as Feedback Instruments in Brief Psychotherapy
Using the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder 7-Item Scale (GAD-7) as Feedback Instruments in Brief Psychotherapy
Status: Enrolling
Updated: 7/18/2017
Christiana Care Health System - Adult Bridge Program
mi
from
Wilmington, DE
Click here to add this to my saved trials
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Status: Enrolling
Updated:  8/8/2017
Northeast Valley Health Corporation- Canoga Park
mi
from
Canoga Park, CA
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Status: Enrolling
Updated: 8/8/2017
Northeast Valley Health Corporation- Canoga Park
mi
from
Canoga Park, CA
Click here to add this to my saved trials
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Status: Enrolling
Updated:  8/8/2017
Northeast Valley Health Corporation- Pacoima
mi
from
Pacoima, CA
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Status: Enrolling
Updated: 8/8/2017
Northeast Valley Health Corporation- Pacoima
mi
from
Pacoima, CA
Click here to add this to my saved trials
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Status: Enrolling
Updated:  8/8/2017
Northeast Valley Health Corporation- San Fernando
mi
from
San Fernando, CA
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Status: Enrolling
Updated: 8/8/2017
Northeast Valley Health Corporation- San Fernando
mi
from
San Fernando, CA
Click here to add this to my saved trials
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Status: Enrolling
Updated:  8/8/2017
Northeast Valley Health Corporation- Santa Clarita
mi
from
Santa Clarita, CA
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Status: Enrolling
Updated: 8/8/2017
Northeast Valley Health Corporation- Santa Clarita
mi
from
Santa Clarita, CA
Click here to add this to my saved trials
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Status: Enrolling
Updated:  8/8/2017
Northeast Valley Health Corporation- Valencia
mi
from
Valencia, CA
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Status: Enrolling
Updated: 8/8/2017
Northeast Valley Health Corporation- Valencia
mi
from
Valencia, CA
Click here to add this to my saved trials
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Status: Enrolling
Updated:  8/8/2017
Northeast Valley Health Corporation- Van Nuys
mi
from
Van Nuys, CA
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Using Telehealth to Deliver Mental Health Services in Primary Care Settings for Children in Underserved Areas
Status: Enrolling
Updated: 8/8/2017
Northeast Valley Health Corporation- Van Nuys
mi
from
Van Nuys, CA
Click here to add this to my saved trials
Feasibility of Heart Rate Variability Biofeedback With In-patient Pregnant Women
Feasibility of Heart Rate Variability Biofeedback as a Stress Reduction Tool for Hospitalized Pregnant Women at the University of North Carolina at Chapel Hill (UNC-CH)
Status: Enrolling
Updated:  8/25/2017
UNC Chapel Hill
mi
from
CHapel Hill, NC
Feasibility of Heart Rate Variability Biofeedback With In-patient Pregnant Women
Feasibility of Heart Rate Variability Biofeedback as a Stress Reduction Tool for Hospitalized Pregnant Women at the University of North Carolina at Chapel Hill (UNC-CH)
Status: Enrolling
Updated: 8/25/2017
UNC Chapel Hill
mi
from
CHapel Hill, NC
Click here to add this to my saved trials
Positive Emotional Processing: Exploring Novel Treatment Targets in Social Phobia
Positive Emotional Processing: Exploring Novel Treatment Targets in Social Phobia - New Data
Status: Enrolling
Updated:  8/31/2017
University of California, San Diego; Psychiatry Clinical Research
mi
from
San Diego, CA
Positive Emotional Processing: Exploring Novel Treatment Targets in Social Phobia
Positive Emotional Processing: Exploring Novel Treatment Targets in Social Phobia - New Data
Status: Enrolling
Updated: 8/31/2017
University of California, San Diego; Psychiatry Clinical Research
mi
from
San Diego, CA
Click here to add this to my saved trials
Helping Older Persons Emerge Stronger
Helping Older Persons Emerge Stronger (HOPES) After Intensive Care Unit Admission
Status: Enrolling
Updated:  9/18/2017
The Ohio State University College of Nursing
mi
from
Columbus, OH
Helping Older Persons Emerge Stronger
Helping Older Persons Emerge Stronger (HOPES) After Intensive Care Unit Admission
Status: Enrolling
Updated: 9/18/2017
The Ohio State University College of Nursing
mi
from
Columbus, OH
Click here to add this to my saved trials
Attention Bias Modification Training for Child Anxiety CBT Nonresponders
Attention Bias Modification Training for Child Anxiety CBT Nonresponders
Status: Enrolling
Updated:  9/20/2017
Florida International University Center for Children and Families
mi
from
Miami, FL
Attention Bias Modification Training for Child Anxiety CBT Nonresponders
Attention Bias Modification Training for Child Anxiety CBT Nonresponders
Status: Enrolling
Updated: 9/20/2017
Florida International University Center for Children and Families
mi
from
Miami, FL
Click here to add this to my saved trials
Interventional Testing of Gene-environment Interactions Via the Verifomics Mobile Application
Interventional Testing of Gene-environment Interactions Via the Verifomics Mobile Application
Status: Enrolling
Updated:  9/27/2017
Verifomics, LLC
mi
from
Dallas, TX
Interventional Testing of Gene-environment Interactions Via the Verifomics Mobile Application
Interventional Testing of Gene-environment Interactions Via the Verifomics Mobile Application
Status: Enrolling
Updated: 9/27/2017
Verifomics, LLC
mi
from
Dallas, TX
Click here to add this to my saved trials
iPad Use in Reducing Anxiety and Depression in Patients Undergoing Bone Marrow Transplant
Project BUCKiPAD: The Evaluation of an iPAD Distribution Program on Anxiety and Depression in Bone and Marrow Transplant Patients
Status: Enrolling
Updated:  9/28/2017
The Ohio State University Comprehensive Cancer Center
mi
from
Columbus, OH
iPad Use in Reducing Anxiety and Depression in Patients Undergoing Bone Marrow Transplant
Project BUCKiPAD: The Evaluation of an iPAD Distribution Program on Anxiety and Depression in Bone and Marrow Transplant Patients
Status: Enrolling
Updated: 9/28/2017
The Ohio State University Comprehensive Cancer Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Generalized Anxiety Disorder and Social Anxiety Disorder: Their Impact on the Processing of Information and Learning
Generalized Anxiety Disorder and Social Anxiety Disorder: Their Impact on the Processing of Social Emotional Information and Instrumental Learning
Status: Enrolling
Updated:  10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Generalized Anxiety Disorder and Social Anxiety Disorder: Their Impact on the Processing of Information and Learning
Generalized Anxiety Disorder and Social Anxiety Disorder: Their Impact on the Processing of Social Emotional Information and Instrumental Learning
Status: Enrolling
Updated: 10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Effects of a CRF1 Receptor Antagonist on Human Startle in Normal Female Volunteers
Effects of a CRF1 Receptor Antagonist on Human Startle in Normal Female Volunteers
Status: Enrolling
Updated:  10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Effects of a CRF1 Receptor Antagonist on Human Startle in Normal Female Volunteers
Effects of a CRF1 Receptor Antagonist on Human Startle in Normal Female Volunteers
Status: Enrolling
Updated: 10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
MRI Study of Brain Activity and Risk for Depression in Adolescents
Neural Circuitry and Risk for Depression in Adolescents: A Study Using Functional Magnetic Resonance Imaging
Status: Enrolling
Updated:  10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
MRI Study of Brain Activity and Risk for Depression in Adolescents
Neural Circuitry and Risk for Depression in Adolescents: A Study Using Functional Magnetic Resonance Imaging
Status: Enrolling
Updated: 10/5/2017
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Efficacy Evaluation of a Unified Transdiagnostic Treatment for Anxiety Disorders
Efficacy Evaluation of a Unified Transdiagnostic Treatment for Anxiety Disorders
Status: Enrolling
Updated:  10/6/2017
Center for Anxiety and Related Disorders, Boston University
mi
from
Boston, MA
Efficacy Evaluation of a Unified Transdiagnostic Treatment for Anxiety Disorders
Efficacy Evaluation of a Unified Transdiagnostic Treatment for Anxiety Disorders
Status: Enrolling
Updated: 10/6/2017
Center for Anxiety and Related Disorders, Boston University
mi
from
Boston, MA
Click here to add this to my saved trials
Negative-Positive Valence Domains in Anxiety and Depression
Latent Constructs: Negative-Positive Valence Domains in Anxiety and Depression
Status: Enrolling
Updated:  10/9/2017
UCSD Psychiatry Clinical Research
mi
from
La Jolla, CA
Negative-Positive Valence Domains in Anxiety and Depression
Latent Constructs: Negative-Positive Valence Domains in Anxiety and Depression
Status: Enrolling
Updated: 10/9/2017
UCSD Psychiatry Clinical Research
mi
from
La Jolla, CA
Click here to add this to my saved trials
Medication Enhanced Rapid Therapy
Medication Enhanced Rapid Therapy
Status: Enrolling
Updated:  10/10/2017
Washington University School of Medicine
mi
from
Saint Louis, MO
Medication Enhanced Rapid Therapy
Medication Enhanced Rapid Therapy
Status: Enrolling
Updated: 10/10/2017
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Therapeutic Massage for Generalized Anxiety Disorder
Therapeutic Massage for Generalized Anxiety Disorder
Status: Enrolling
Updated:  10/11/2017
Group Health Research Institute
mi
from
Seattle, WA
Therapeutic Massage for Generalized Anxiety Disorder
Therapeutic Massage for Generalized Anxiety Disorder
Status: Enrolling
Updated: 10/11/2017
Group Health Research Institute
mi
from
Seattle, WA
Click here to add this to my saved trials
MDMA-assisted Therapy in People With Anxiety Related to Advanced Stage Cancer
Phase II Dose-response Pilot Study of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy in Subjects With Anxiety Associated With Advanced-stage Cancer.
Status: Enrolling
Updated:  10/12/2017
McLean Hospital
mi
from
Belmont, MA
MDMA-assisted Therapy in People With Anxiety Related to Advanced Stage Cancer
Phase II Dose-response Pilot Study of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy in Subjects With Anxiety Associated With Advanced-stage Cancer.
Status: Enrolling
Updated: 10/12/2017
McLean Hospital
mi
from
Belmont, MA
Click here to add this to my saved trials
Transdiagnostic Behavioral Activation Therapy for Youth Anxiety and Depression
The Function of Avoidance in Depressed Behavior and a Pilot of Transdiagnostic Behavioral Activation Therapy
Status: Enrolling
Updated:  10/15/2017
Rutgers University
mi
from
Piscataway, NJ
Transdiagnostic Behavioral Activation Therapy for Youth Anxiety and Depression
The Function of Avoidance in Depressed Behavior and a Pilot of Transdiagnostic Behavioral Activation Therapy
Status: Enrolling
Updated: 10/15/2017
Rutgers University
mi
from
Piscataway, NJ
Click here to add this to my saved trials
Implementing a Paced Deep Breathing Module to Decrease Preoperative Anxiety in Gynecological Surgery Patients
Implementing a Paced Deep Breathing Module to Decrease Preoperative Anxiety in Gynecological Surgery Patients
Status: Enrolling
Updated:  10/17/2017
The Mayo Clinic
mi
from
Rochester, MN
Implementing a Paced Deep Breathing Module to Decrease Preoperative Anxiety in Gynecological Surgery Patients
Implementing a Paced Deep Breathing Module to Decrease Preoperative Anxiety in Gynecological Surgery Patients
Status: Enrolling
Updated: 10/17/2017
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Hormones and Social Anxiety Disorder Treatment
Effect of Hormones on Response to Exposure Therapy for Social Anxiety Disorder
Status: Enrolling
Updated:  10/19/2017
University of Texas at Austin
mi
from
Austin, TX
Hormones and Social Anxiety Disorder Treatment
Effect of Hormones on Response to Exposure Therapy for Social Anxiety Disorder
Status: Enrolling
Updated: 10/19/2017
University of Texas at Austin
mi
from
Austin, TX
Click here to add this to my saved trials
Delivery of Anxiety Disorder Treatment in Addictions Centers
Adaptation of CALM for Comorbid Anxiety and Substance Use Disorders
Status: Enrolling
Updated:  10/24/2017
Matrix Institute on Addictions
mi
from
Los Angeles, CA
Delivery of Anxiety Disorder Treatment in Addictions Centers
Adaptation of CALM for Comorbid Anxiety and Substance Use Disorders
Status: Enrolling
Updated: 10/24/2017
Matrix Institute on Addictions
mi
from
Los Angeles, CA
Click here to add this to my saved trials